Acquisition / Media Intelligence
Fund what creates incremental demand.
Platform reporting is abundant, but it cannot defend what demand was truly caused or where the next dollar should go.
Which channels deserve the next dollar - and which do not?
Allocation desk / planning range
- Decision arena
- Portfolio response / capital move
- Evidence state
- Modeled proposal / approval-gated
TXMedia Optimizer
Illustrative framework / no observed outcomeWeek 12
Open evidence record Decision workspace / TX-WS-MED-01
- Artifact
- Decision workspace
- Evidence status
- Illustrative framework / no observed outcome
- Record ID
- TX-WS-MED-01
- Record
- Media Optimizer decision workspace / rolling 12 weeks / illustrative values
- Decision question
- Where should the next media dollar move, within what downside boundary?
Portfolio governed$4.8mannualized media
Proposed move$180kwithin portfolio
Modeled contribution+$220–390k80% planning range
Decision workspace · sanitized reconstruction · illustrative valuesSignal → funding decision → measurement rule Engagement brief
A bounded question. A defensible decision.
- Built for
- CMO, growth, media, and finance leaders making consequential allocation decisions.
- Entry diagnostic
- Media incrementality and capital-efficiency review
- Decision record
- Marginal-return allocation record and realized-review rule
- Client commitment
- A weekly decision forum plus governed access to spend, outcome, and experiment data.
The analytical work
Evidence enters. A capital or operating decision leaves.
Inputs we interrogate
- Channel, campaign, spend, and conversion history
- Commercial targets, contribution economics, and constraints
- Prior tests, holdouts, geo structure, and measurement maturity
How we establish the answer
- Reconcile reporting into a decision-grade evidence base
- Estimate baseline demand and incremental contribution
- Model marginal response, saturation, and uncertainty
- Convert findings into governed reallocation scenarios
Evidence sequence
Not dashboards for display. Evidence for the next move.
Each view is selected to answer a buyer question: what did we examine, what did we find, and what should the business do now?
TXMedia Optimizer
Illustrative framework / no observed outcomeWeek 12
Open evidence record Decision workspace / TX-WS-MED-01
- Artifact
- Decision workspace
- Evidence status
- Illustrative framework / no observed outcome
- Record ID
- TX-WS-MED-01
- Record
- Media Optimizer decision workspace / rolling 12 weeks / illustrative values
- Decision question
- Where should the next media dollar move, within what downside boundary?
Portfolio governed$4.8mannualized media
Proposed move$180kwithin portfolio
Modeled contribution+$220–390k80% planning range
Decision workspace · sanitized reconstruction · illustrative valuesSignal → funding decision → measurement rule Method record Illustrative framework / no observed outcome
Method figure Figure 01 / analytical interpretation This is a source deliverable for method inspection, not a product interface.
Open evidence record Research model / TX-METH-MED-01
- Artifact
- Research model
- Evidence status
- Illustrative framework / no observed outcome
- Record ID
- TX-METH-MED-01
- Record
- Marginal-return framework / illustrative values
- Decision question
- Where does the next media dollar still earn incremental return?
Source record / TX-METH-MED-01 Research method plate Curated source deliverable / method artifact, not a live product view
Tangentix marginal-return framework / illustrative values - What Tangentix found
- Average return obscured the point where incremental media started producing weaker gain.
- Decision that follows
- Fund the next dollar only within the response range that clears the agreed downside boundary.
Decision state Illustrative framework / no observed outcome
Open evidence record Decision workspace / TX-WS-MED-02
- Artifact
- Decision workspace
- Evidence status
- Illustrative framework / no observed outcome
- Record ID
- TX-WS-MED-02
- Record
- Weekly capital-decision framework / illustrative values
- Decision question
- What should move, who owns it, and what condition releases the capital?
Source record / TX-WS-MED-02 Decision workspace record Curated source deliverable / not a live product view
Tangentix decision-governance framework / illustrative values - What Tangentix found
- Reported efficiency concealed different marginal economics across channels.
- Decision that follows
- Reallocate within agreed risk limits and measure the realized effect.
Open evidence record Executive brief / TX-BRIEF-MED-01
- Artifact
- Executive brief
- Evidence status
- Sanitized reconstruction
- Record ID
- TX-BRIEF-MED-01
- Record
- Sanitized investment committee record / proposal state / illustrative values
- Decision question
- What can we authorize now, and what evidence releases the next dollar?
- Decision owner
- CMO or growth executive · finance reviewer
Method record Real methodology / anonymized evidence
Method figure Figure 03 / analytical interpretation This is a source deliverable for method inspection, not a product interface.
Open evidence record Research model / TX-METH-INC-02
- Artifact
- Research model
- Evidence status
- Real methodology / anonymized evidence
- Record ID
- TX-METH-INC-02
- Record
- Sanitized methodology plate / client values withheld
- Decision question
- Does response strengthen with exposure in a way consistent with an earned effect?
Source record / TX-METH-INC-02 Research method plate Curated source deliverable / method artifact, not a live product view
Real anonymized methodology deliverable - What Tangentix found
- The response pattern supported a bounded incremental effect rather than full platform credit.
- Decision that follows
- Set the next investment range against causal evidence and confidence, not a single ROAS number.
What your team receives
A capital-allocation record your team can act on.
The package makes the baseline, marginal-return boundary, recommendation, owner, and realized-review rule legible before capital moves.
- 01Incrementality test plan
- 02Marginal-return curves
- 03Budget reallocation scenarios
How we keep score
- Incremental revenue or contribution
- Marginal return by channel
- Portfolio efficiency and concentration risk
- Forecast versus realized allocation impact
Start with media incrementality and capital-efficiency review
Put the next dollar under a better rule.
Bring the allocation under dispute. We will identify the baseline, evidence boundary, and decision rule needed before more capital moves.
Request a fit call